IQMDW
Income statement / Annual
Last year (2022), Intelligent Medicine Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Intelligent Medicine Acquisition Corp.'s net income was $11.41 M.
See Intelligent Medicine Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$1.28 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.28 M
|
$0.00
|
| Other Expenses |
$0.00 |
$0.00 |
| Operating Expenses |
$1.28 M |
$0.00 |
| Cost And Expenses |
$1.28 M |
$0.00 |
| Interest Income |
$0.00 |
$0.00 |
| Interest Expense |
-$26.51 M |
$0.00 |
| Depreciation &
Amortization |
$0.00
|
$236,558.00
|
| EBITDA |
-$14.54 M
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
| Total Other
Income/Expenses Net |
$26.74 M
|
$0.00
|
| Income Before Tax |
$11.97 M |
$0.00 |
| Income Before Tax Ratio
|
0
|
0
|
| Income Tax Expense |
$562,567.00 |
$0.00 |
| Net Income |
$11.41 M |
$0.00 |
| Net Income Ratio |
0 |
0 |
| EPS |
2.2 |
0 |
| EPS Diluted |
2.2 |
0 |
| Weighted Average Shares
Out |
$5.18 M
|
$25.88 M
|
| Weighted Average Shares
Out Diluted |
$5.18 M
|
$25.88 M
|
| Link |
|
|
